TY - JOUR
KW - *Abortion, Spontaneous/epidemiology
KW - England/epidemiology
KW - Female
KW - Humans
KW - Infant
KW - Infant, Newborn
KW - Pregnancy
KW - *Pregnancy Outcome/epidemiology
KW - Retrospective Studies
KW - Uterine Hemorrhage
KW - vaccination
KW - Background rate
KW - Low-risk pregnancy
KW - Maternal immunization trial
KW - Maternal vaccination
KW - Miscarriage
KW - Pharmacovigilance
KW - Pregnancy outcomes
KW - Pregnancy-related events of interest
KW - Preterm delivery
AU - M. Riley
AU - D. Lambrelli
AU - S. Graham
AU - O. Henry
AU - A. Sutherland
AU - A. Schmidt
AU - N. Sawalhi-Leckenby
AU - R. Donaldson
AU - S. Stoszek
AD - GSK, 14200 Shady Grove Rd, Rockville, MD, 20850, Washington, USA. megan.x.riley@gsk.com.
Evidera, 201 Talgarth Rd, Hammersmith, London, W6 8BJ, UK.
GSK, 14200 Shady Grove Rd, Rockville, MD, 20850, Washington, USA.
Moderna, Cambridge, MA, USA.
Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.
AN - 35650569
BT - BMC Pregnancy Childbirth
C2 - PMC9157029
DO - 10.1186/s12884-022-04769-x
DP - NLM
ET - 2022/06/02
LA - eng
M1 - 1
N1 - 1471-2393
Riley, Megan
Lambrelli, Dimitra
Graham, Sophie
Henry, Ouzama
Sutherland, Andrea
Schmidt, Alexander
Sawalhi-Leckenby, Nicola
Donaldson, Robert
Stoszek, Sonia K
Journal Article
BMC Pregnancy Childbirth. 2022 Jun 1;22(1):461. doi: 10.1186/s12884-022-04769-x.
PY - 2022
SN - 1471-2393
EP - 461
T2 - BMC Pregnancy Childbirth
TI - Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England
VL - 22
ER -